Skip to content
top-banner-landingpage-ECP2023-Dublin

Meet us at ECP 2023 in Dublin, Ireland

We're thrilled to announce that we'll be participating in the European Congress of Pathology (ECP 2023) in Dublin from 9-13 September.

Here's what you can expect from us:

Looking to overcome the IT and installation challenges of implementing a digital pathology workflow?

You're invited to try out and get a sneak peak of Oncotopix Web, a new AI-powered solution that enables easy accessibility to automated image analysis for pathology labs that do not have a full digital workflow and infrastructure. The cloud-based platform eliminates the need for software installation and allows easy analysis of images. It offers a graphical user interface accessible via the web, allowing users to upload images for analysis by pre-existing, fully automated, APPs in the cloud. The current menu includes PD-L1 and Ki-67, with plans to expand to other existing APPs like ER/PR/HER2 and more.

Simply bring your anonymized Ki67 or PD-L1 images to our booth, and we will upload them together to the platform. It will automatically analyze the slides and send you an email report with results. If you don't have slides available, we have test slides for you to use.

Discover our IVDR-cleared and fully automated next-generation Ki67 algorithm for IHC biomarker analysis

Visit our booth to learn about our new next-generation Ki67 algorithm that provides diagnostic decision support for pathologists. The algorithm has been cleared under the European In-Vitro Diagnostic Regulations (IVDR) and is designed to be fully automated, enabling pathologists to become more productive without manual steps.

Paul van Diest, Head of Pathology at UMC Utrecht, had this to say about it:

"The Visiopharm algorithm is helping us achieve standardization in the scoring of Ki67 for breast cancer patients. We look forward to having the algorithm fully automated and integrated into our workflow, saving us time and effort while also improving the accuracy and consistency of our results."

Symposium talk: AI for Accurate Quantification of Therapeutic Targets

Don't miss this recommended talk - AI for Accurate Quantification of Therapeutic Targets - as part of Agilent's lunch satellite symposium on Tuesday 12 September at 13:00-14:30.

Join our partner, Agilent, for an engaging satellite symposium during lunch. Professor Paul van Diest, Head of the Pathology Department at University Medical Center, Utrecht, The Netherlands, will be taking the stage for his talk on "AI for Accurate Quantification of Therapeutic Targets." In this session, Professor Diest will delve into the realm of AI-driven advancements in quantifying therapeutic targets. With a focus on digital pathology, he will explore how objective quantitation of these targets is made possible through image analysis and artificial intelligence (AI). This session promises to provide an insightful overview of the cutting-edge field of cancer biomarker quantitation by AI, covering protein targets, molecular changes, and tumor-infiltrating lymphocytes. Agilent will offer a lunch box during the symposium, and you will receive a digital certification of attendance.

Discover our partnerships

NanoString

Want to improve your GeoMx IF analysis and save time on the ROI/AOI selection step? We've teamed up with NanoString to develop automated, AI-driven image analysis for region selection in GeoMx. Visit our booth or stop by the NanoString at booth #1731 from 13:30-14:00 PM each day for a preview. Don't miss out on this opportunity to improve your GeoMx workflow.

Standard BioTools

We've partnered up with Standard BioTools to deliver our AI-driven highplex analysis software for faster, more streamlined analyses as a part of all Hyperion Imaging Systems, providing out-of-the-box solutions to accelerate highplex IMC studies. 

Together, we deliver Phenoplex with Hyperion systems for a unified image analysis pipeline and are developing data analysis methods for the Maxpar IMC Cell Segmentation kit to simplify cell segmentation and better extract meaningful biological data. 

If you're looking for a faster and more streamlined analysis of data acquired through Hyperion, make sure to visit our booths #1224 and #612 to learn more.

Posters being presented at AACR

Title: TP53 gain-of-function mutation modulates the immunosuppressive microenvironment in non-HPV associated oral squamous cell carcinoma

Session Date and Time: Sunday Apr 16, 2023 1:30 PM - 5:00 PM

Published Abstract Number: 619

Poster Board Number: 20

Poster Section: 21

Authors: Y. Shi et al. from Xi'an Jiaotong University, China,; with MD Anderson Cancer Center

Title: Multiplex immunofluorescence and image analysis to investigate the role of the immune contexture and fibroblast activation for tumor cell budding in colorectal cancer

Session Date and Time: Sunday Apr 16, 2023 1:30 PM - 5:00 PM

Published Abstract Number: 1018

Poster Board Number: 28

Poster Section: 41

Authors: D. Zielinski et al. from Discovery Life Sciences

Title: Precision immuno-oncology (IO) ISH/IF multiplex panel: Spatial detection of cytokines and IO biomarkers

Session Date and Time: Monday Apr 17, 2023 1:30 PM - 5:00 PM

Published Abstract Number: 2322

Poster Board Number: 3

Poster Section: 45

Authors: B. Dennison et al. from Lanterne Dx

Title: Multiplex proteomics profiling with the imaging mass cytometry (IMC) identifies immune cell phenotypes associated with high NOS2/COX2 expression in ER- negative and TNBC patients

Session Date and Time: Tuesday Apr 18, 2023 1:30 PM - 5:00 PM

Published Abstract Number: 3588

Poster Board Number: 13

Poster Section: 3

Authors: M. Pore et al. from NCI Frederick, MD

Title: A comprehensive guided workflow for highplex imaging, tissue segmentation, and multiplex cellular phenotyping for tumor microenvironment analysis

Session Date and Time: Tuesday Apr 18, 2023 1:30 PM - 5:00 PM

Published Abstract Number: 4625

Poster Board Number: 15

Poster Section: 4

Authors: B. O’Neill et al. from Visiopharm; with Standard Bio Tools

Posters

banner-other-poster-coming-soon-right

Poster #445 | Inter-laboratory variability of HER2-low analysis using Artificial Intelligence
Nils ‘t Hart, M. Eenkhoorn, H. Høeg, D. Dabbs

Session: Poster Session Breast Pathology
Date: 10/09/2023
Time: 09:30 - 10:30

In this poster, the authors show the results of a HER2 test staining on celllines from 32 laboratories in the Netherlands, analysed with Qualitopix. Learn how the antibodies differ in their sensitivity level and which ones resulted in consistent HER2-low stain. 

banner-other-poster-coming-soon-right

E-Poster #586 | Improving PD-L1 quality control using a dynamic range cell line and Qualitopix analysis
Nils ‘t Hart, L. Gal, M. Grønning Nielsen, H. Høeg

In this poster, the authors evaluated intra-laboratory variability of PD-L1 staining in NSCLC using a dynamic range cell line combined with Qualitopix analysis. Learn how this test approach results in an improvement in identifying optimal staining for cases near or at its analytical cut-off and even allowed early detection of a faulty immunostainer.

For all posters, visit ECP's Abstracts eBook and search Visiopharm in the top right-corner.

Say hello to our team at booth #31

Do you have questions about digital pathology? Visit our friendly team at booth #31 and get the answers you need. Our experts are available to provide you with the latest insights on digital pathology techniques and applications. Keep an eye out for the friendly faces – they're waiting to welcome you to our booth

Martin Kristensson

Martin Kristensson

SVP, Global Clinical Sales

Niklas Petersen

Niklas Petersen

Technical Sales Specialist
Sharmila Mistry

Sharmila Mistry

New Business Account Executive
Rickard Lindelöf-1

Rickard Lindelöf

SVP, Clinical Business Development

If you have a burning question you can't wait to ask at ECP, don't hesitate to get in touch with our team here.

Get your free #VisiopharmCartoons artwork at our booth

large-Qualitopix cartoon

Get automated reporting to document staining consistency records to support documentation and audit preparation with Qualitopix ™ from Visiopharm.